MedX Holdings Inc (MEDH)

[nodummy]

New filing confirms what I said earlier.

All the dilution over the summer was due to 60,000,000 free trading shares being issued to Mark Miller's good buddy - Gary Kouletas

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158933534

https://backend.otcmarkets.com/otcapi/company/financial-report/262789/content



Remember when the price was pumped up to $.066/share in July - it was just a pump and dump for Kouletas to profit as much as possible off those 60,000,000 shares.


But don't sleep on this very important change to the remaining Notes.

The $18,850 Note owed to Miller's other close friend, Richard Kilchesky (Northwoods Elite LLC), that last checked in at $19,920 after interest, has grown to $21,997, and the conversion rate has been changed from $.001/share to $.0001/share:

https://backend.otcmarkets.com/otcapi/company/financial-report/262789/content



The future dilution picture has changed very much for the worse:

Kilchesky's $21,997 debt can convert into 219,970,000 free trading shares starting on 10/23/20 (the mature date - which has already passed).

Then, Miller's $73,898 debt will convert into 73,898,000 free trading shares starting on 12/19/20 - though I expect they will also change this one to a conversion rate of $.0001/share in the next filings.

Howard Salamon/David Goulding's back dated Note, portions of which had already been converted into 10,000,000 free trading shares over the summer, still had 10,000,000 free trading shares to go as of September 30, 2020 - but since the float grew by 10,000,000 shares in October, they obviously finished converting the Salamon/Goulding Note between October 1, 2020 and October 23, 2020 to get ahead of the Kilchesky Note.



So MEDH is facing at minimum of 293,868,000 shares of dilution in the next several months (219,970,000 shares from the Kilchesky Note and 73,898,000 shares from the Miller Note).

And if they lower the conversion rate on the Miller Note to $.0001/share as I suspect, it becomes 1,293,868,000 shares of future dilution (219,970,000 shares from the Kilchesky Note and 738,980,000 shares from the Miller Note), truly making MEDH the next IGEX, KYNC, CNNA.